Please login to the form below

Not currently logged in
Email:
Password:

Bayer sees increase in Q1 sales

Bayer has reported a five per cent increase in first-quarter sales of pharmaceuticals to €2.6bn compared to 2008, for products such as Betaferon and Nexavar

Bayer has reported a five per cent increase in first-quarter sales of pharmaceuticals to €2.6bn compared to 2008, for products such as Betaferon and Nexavar. Sales for the company's HealthCare unit gained three per cent to €3.8bn.

Betaferon/Betaseron posted a 9.9 per cent sales increase to €301m over the comparable quarter, while Nexavar's revenue jumped 36 per cent to €137m. The German pharmaceutical and chemical company also reported that combined quarterly revenue from contraceptives YAZ, Yasmin and Yasminelle increased 7.4 per cent to €319m.

CEO Werner Wenning said "our pharmaceutical business saw pleasing growth overall" and added that Bayer's HealthCare unit "plans to achieve currency-adjusted growth rates ahead of the market average in all divisions" in 2009.

However, overall company profit decreased 44 per cent to €425m due to the impact of the global economic recession on other business segments such as plastics and adhesive chemicals. Quarterly group revenue was 7.5 per cent lower than the same period last year at €7.9bn.

30th April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi’s philosophy is to go that extra mile. Look deeper. Discuss further.Study longer. Work harder.This focussed work ethic combined...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics